$18.90 – $51.03Price range: $18.90 through $51.03
Pioglit 30 Tablet (Pioglitazone Tablets) is a prescription medicine for adults with type 2 diabetes. It helps the body use insulin more effectively, so blood sugar levels can come down over time. Many people take it once daily, with or without food, alone or with other diabetes medicines. It is not for type 1 diabetes or diabetic ketoacidosis. Dose is individualised and checked with lab tests.
| Active Ingredient: | Pioglitazone 30mg |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Sun Pharma Laboratories Ltd |
| Packaging: | 10 tablets in 1 strip |
| Strength: | 30mg |
| Delivery Time: | 6 To 15 days |
Use Coupon Code: HR20 for 20% OFF
| Variant | Price | Units | Quantity | Add to Cart |
|---|---|---|---|---|
| 30 Tablet/s | $18.90 | $0.63 / Tablet | ||
| 60 Tablet/s | $35.91 | $0.60 / Tablet | ||
| 90 Tablet/s | $51.03 | $0.57 / Tablet |
Pioglit 30 Tablet (Pioglitazone) is prescribed to help improve blood sugar control in adults with type 2 diabetes, especially when insulin resistance is part of the problem.
If you have ever heard your clinician say, “Your body makes insulin, but it’s not using it well,” that is the basic issue this medication targets.
It works best as part of a full plan that includes food choices, physical activity, and regular follow-ups, not as a substitute for them.
Pioglitazone belongs to a group of medicines called thiazolidinediones (often shortened to TZDs). In everyday terms, it helps your cells respond better to insulin. That can lower blood glucose and improve A1C over time.
Pioglitazone is used for type 2 diabetes. It may be prescribed alone or paired with other diabetes medicines when a single medication is not enough.
The goal is steady, long-term improvement in blood sugar numbers, not an immediate drop after a single dose. This medication is not used for type 1 diabetes. It is also not used to treat diabetic ketoacidosis.
Pioglitazone is not a “quick” medication. Many people do not feel a direct effect day to day, even when the medicine is doing its job.
Clinicians usually track progress by reviewing home glucose readings and lab results, such as A1C, over the next several weeks to months.
Fluid retention and heart failure: Pioglitazone can cause fluid retention and heart failure. In some people, that can trigger or worsen heart failure. Contact your prescriber promptly if you notice swelling in your ankles or feet, unusual shortness of breath, or rapid weight gain over a short period.
Low blood sugar with certain combinations: On its own, pioglitazone is not known as a major cause of hypoglycemia. The risk can increase when combined with medicines that increase insulin levels, such as insulin or sulfonylureas. Your clinician may adjust other doses to lower that risk.
Weight gain and swelling: Some weight gain can happen, and it is not always just “extra calories.” Fluid retention can contribute, and that is one reason unexpected weight changes should be taken seriously.
Bone fracture risk: TZD medicines, including pioglitazone, have been linked with a higher fracture risk in some groups, especially women. If you have risk factors for osteoporosis, it is worth discussing before starting.
Bladder cancer history: There has been ongoing discussion about a possible association between pioglitazone and bladder cancer risk. If you have a current or past bladder cancer diagnosis, make sure your prescriber knows, since that history can affect whether this medicine is a good fit.
Liver and vision concerns: Liver-related side effects are uncommon but possible, and vision changes should never be ignored. If you develop yellowing of the skin or eyes, dark urine, persistent nausea, or new blurry vision, get medical advice right away.
Pioglitazone can interact with other medications. For example, gemfibrozil can raise pioglitazone levels, and rifampin can lower them. Some hormone-based birth control may be less reliable for certain people when used with pioglitazone.
The safest approach is to share a complete medication list with your clinician and pharmacist, including supplements.
This is a prescriber-level question. Diabetes treatment in pregnancy is handled differently, and your clinician will choose the safest option based on your situation.
No. They work in different ways. Metformin primarily lowers hepatic glucose production and improves insulin sensitivity, while pioglitazone primarily improves insulin sensitivity in tissues. Some people are prescribed both.
Sometimes, yes, but the combination needs close supervision because side effects and the risk of low blood sugar can change when medicines are combined.
It can influence lipid levels in some people. If cholesterol management is part of your care plan, your clinician may monitor labs and adjust treatment as needed.
It can cause small drops in hemoglobin/hematocrit in some people, often related to fluid changes. If you feel unusual fatigue or weakness, tell your prescriber so they can evaluate it.